Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Biotech
Allogene reports patient death tied to mAb in CAR-T pivotal trial
Given the patient death, the company is dropping the monoclonal antibody called ALLO-647 completely, CEO David Chang told Fierce.
Gabrielle Masson
Aug 1, 2025 8:30am
Fierce Pharma
Prasad exit signals more permissive FDA for cell and gene field
Jul 31, 2025 9:10am
Fierce Pharma
FDA taps new CDER chief as acting CBER head after Prasad exit
Jul 30, 2025 1:10pm
Cardiosense scores FDA clearance for wearable cardiac monitor
Jul 30, 2025 11:30am
FDA delays hit clinical trial launch decisions
Jul 30, 2025 10:29am
Fierce Pharma
Vinay Prasad departs FDA amid controversy over gene therapy
Jul 30, 2025 9:33am